… NLRP3 inflammasome activation pathway. Second, we review the cellular/molecular
mechanisms of NLRP3 inflammasome … the involvement of the NLRP3 inflammasome in the …

… In this review, we will discuss the NLRP3 inflammasome as a … on current strategies for targeting
the NLRP3 inflammasome, … and that targeting NLRP3 is a promising therapeutic strategy. …

… Pharmacological inhibition of NLRP3 activation results in potent therapeutic effects in a
wide variety of rodent models of inflammatory diseases, effects that are mirrored by genetic …

… about the pathophysiological role of NLRP3 inflammasome pathways in such … NLRP3
inflammasome by phytochemicals could represent a promising molecular target for the therapeutic …

… of CKD, but the mechanism behind inflammasome activation in CKD remains obscure.In this
… the NLRP3 inflammasome in CKD and new strategies targeting the NLRP3 inflammasome. …

… mechanisms of NLRP3 inflammasome activation, how dysregulation of NLRP3 inflammasome
activation causes disease, and potential therapeutics that inhibit NLRP3 inflammasome …

… through the regulation of NLRP3 inflammasome assembly. In this report, we present an
overview of studies regarding NLRP3 inflammasome-based therapeutic development of natural …

… NLRP3 inflammasome activation. Furthermore, we discuss the implications of the NLRP3
inflammasome … on targeting the NLRP3 inflammasome in DR therapeutics with the expectation …

… Therapies targeting the NLRP3 inflammasome have attractive potential. However, several
… will be elicited in vivo if the therapeutic strategies are designed by targeting the upstream or …

… of the molecular mechanisms associated with the onset and progression of AD is critical to
provide a theoretical basis for the establishment of novel preventive and therapeutic strategies…